Evidence map›Paper›PMID 40814051›Full record

ArticleHarm reduction journal2025

Switching and substantial reductions in cigarette consumption concurrent with use of a heated tobacco product among adults who smoke in Czechia: an actual use study.

Christopher Russell, Gabriel Barnard, Venus Marza, Sophie Notley, Thomas Nahde, Martin Fitzpatrick, Layla Malt, Matthew Stevenson, Sarah Weaver, Neil McKeganey

Abstract read
In one paragraph

Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christopher RussellRussell Burnett Research and Consultancy Ltd, Paxton House, 11 Woodside Crescent, Charing Cross, Glasgow, G3 7UL, UK. russellburnettrc@gmail.com.
Gabriel BarnardCentre for Substance Use Research Ltd, 4 Woodside Terrace, Glasgow, G3 7UY, UK.
Venus MarzaCentre for Substance Use Research Ltd, 4 Woodside Terrace, Glasgow, G3 7UY, UK.
Sophie NotleyCentre for Substance Use Research Ltd, 4 Woodside Terrace, Glasgow, G3 7UY, UK.
Thomas NahdeImperial Brands Reemtsma GmbH, Behringstrasse 122a, 22763, Hamburg, Germany.
Martin FitzpatrickImperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.
Layla MaltImperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.
Matthew StevensonImperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.
Sarah WeaverImperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.
Neil McKeganeyCentre for Substance Use Research Ltd, 4 Woodside Terrace, Glasgow, G3 7UY, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe potential for heated tobacco products (HTPs) to reduce smoking-related harm depends, in part, on how adults who smoke cigarettes use HTPs in their everyday lives, and the extent to which HTPs come to be used as a replacement for all or most of the cigarettes that a person smokes. This study assessed changes in cigarette smoking behaviour among adults who smoke when using HTPs in near-to-real world settings for six weeks.

methodsParticipants were 332 adults aged 19 years and older who smoked between 5 and 30 cigarettes per day, on average, living in Prague or Brno, Czechia, who reported no intention to quit smoking within the next three months but reported a positive likelihood of using the PULZE + iD Heated Tobacco System ('the Study Product') on a regular basis following a brief trial use period. Participants were given a personal prepaid debit card to purchase packs of consumable heated tobacco sticks ('iD Sticks', the Study Sticks) in their choice of 12 commercially available flavours, directly from retailers in the community, to use as desired for six weeks. Participants recorded their daily consumption of cigarettes, Study Sticks, and other tobacco products in an electronic diary for 42 consecutive days. Data were collected between May-November 2023.

resultsDuring Week-6 of ad libitum use of the Study Product, 16.0% of participants had completely switched from cigarettes to the Study Product (i.e., past 7-day use of the Study Product and zero cigarettes smoked) and 33.7% had reduced their daily cigarette consumption by 50-99% while continuing to use the Study Product. On average, weekly cigarette consumption reduced by 35.6% (1.9 fewer packs per participant) during Week-1 and 45.2% (2.4 fewer packs per participant) during Week-6, compared to the pre-study baseline week. Most Study Sticks consumed during the Observational Phase were flavoured to taste like fruit (40.1%), followed by tobacco (38.4%) and menthol/mint (21.5%). At Week-24, 63.6% continued to purchase Study Sticks with their own money and 50.9% were using the Study Product as a complete or majority replacement for cigarettes.

conclusionsThe Study Product has potential to help adults who smoke to completely switch away from cigarettes or substantially reduce cigarette consumption in the short- to medium-term in real-world settings.

Indexed as

Cigarette SmokingSmoking CessationTobacco ProductsAdultAgedCzech RepublicFemaleHot TemperatureHumansMaleMiddle AgedYoung AdultActual useCigaretteHeated tobaccoObservationalSmokingTobacco

Identifiers

PMID40814051
PMCPMC12351828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.